“We tested the hypothesis that the irreversible &ggr;-amino butyric acid transaminase inhibitor, &ggr;-vinyl &ggr;-amino butyric acid [vigabatrin (VGB)], would reduce ethanol reinforcement and enhance the discriminative-stimulus effect of ethanol, effectively reducing ethanol intake.”